| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 3808987
[patent_doc_number] => 05831081
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-11-03
[patent_title] => 'Process for the purification of water-soluble cyclodextrin derivatives'
[patent_app_type] => 1
[patent_app_number] => 8/454940
[patent_app_country] => US
[patent_app_date] => 1995-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 4024
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/831/05831081.pdf
[firstpage_image] =>[orig_patent_app_number] => 454940
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/454940 | Process for the purification of water-soluble cyclodextrin derivatives | May 30, 1995 | Issued |
Array
(
[id] => 3660730
[patent_doc_number] => 05624839
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-04-29
[patent_title] => 'Process for culturing hepatocytes for formation of spheroids'
[patent_app_type] => 1
[patent_app_number] => 8/453932
[patent_app_country] => US
[patent_app_date] => 1995-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 5
[patent_no_of_words] => 10975
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/624/05624839.pdf
[firstpage_image] =>[orig_patent_app_number] => 453932
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/453932 | Process for culturing hepatocytes for formation of spheroids | May 29, 1995 | Issued |
Array
(
[id] => 3845199
[patent_doc_number] => 05708152
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-01-13
[patent_title] => 'N-substituted chitosan derivatives in a process for their preparation'
[patent_app_type] => 1
[patent_app_number] => 8/451324
[patent_app_country] => US
[patent_app_date] => 1995-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9233
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/708/05708152.pdf
[firstpage_image] =>[orig_patent_app_number] => 451324
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/451324 | N-substituted chitosan derivatives in a process for their preparation | May 25, 1995 | Issued |
| 08/451563 | METHOD OF MANUFACTURING NON-ABSORBABLE SYNTHETIC SULFATED POLYSACCHARIDES | May 25, 1995 | Abandoned |
Array
(
[id] => 3725184
[patent_doc_number] => 05672693
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-09-30
[patent_title] => 'Glycosphingolipids'
[patent_app_type] => 1
[patent_app_number] => 8/451729
[patent_app_country] => US
[patent_app_date] => 1995-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 3538
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/672/05672693.pdf
[firstpage_image] =>[orig_patent_app_number] => 451729
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/451729 | Glycosphingolipids | May 25, 1995 | Issued |
Array
(
[id] => 3957865
[patent_doc_number] => 05936076
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-08-10
[patent_title] => '.alpha.galactosylceramide derivatives'
[patent_app_type] => 1
[patent_app_number] => 8/450109
[patent_app_country] => US
[patent_app_date] => 1995-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 32975
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/936/05936076.pdf
[firstpage_image] =>[orig_patent_app_number] => 450109
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/450109 | .alpha.galactosylceramide derivatives | May 24, 1995 | Issued |
Array
(
[id] => 3513538
[patent_doc_number] => 05512470
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-04-30
[patent_title] => 'Method for inhibiting sialidase activity'
[patent_app_type] => 1
[patent_app_number] => 8/444593
[patent_app_country] => US
[patent_app_date] => 1995-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 23
[patent_no_of_words] => 16139
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 285
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/512/05512470.pdf
[firstpage_image] =>[orig_patent_app_number] => 444593
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/444593 | Method for inhibiting sialidase activity | May 18, 1995 | Issued |
Array
(
[id] => 3882970
[patent_doc_number] => 05776720
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-07-07
[patent_title] => 'Assay reagent'
[patent_app_type] => 1
[patent_app_number] => 8/443776
[patent_app_country] => US
[patent_app_date] => 1995-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 45
[patent_figures_cnt] => 50
[patent_no_of_words] => 37049
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/776/05776720.pdf
[firstpage_image] =>[orig_patent_app_number] => 443776
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/443776 | Assay reagent | May 17, 1995 | Issued |
| 08/443761 | THERAPEUTIC USE OF GANGLIOSIDE GM1 IN THE TREATMENT OF SPINAL CORD INJURY | May 17, 1995 | Abandoned |
Array
(
[id] => 3531875
[patent_doc_number] => 05583213
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-12-10
[patent_title] => 'Process to activate sulfated polysaccharides'
[patent_app_type] => 1
[patent_app_number] => 8/439522
[patent_app_country] => US
[patent_app_date] => 1995-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 4
[patent_no_of_words] => 4209
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/583/05583213.pdf
[firstpage_image] =>[orig_patent_app_number] => 439522
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/439522 | Process to activate sulfated polysaccharides | May 11, 1995 | Issued |
Array
(
[id] => 3598734
[patent_doc_number] => 05559104
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-09-24
[patent_title] => 'Procedure for the purification of hyaluronic acid and fraction of pure hyaluronic acid for ophthalmic use'
[patent_app_type] => 1
[patent_app_number] => 8/439437
[patent_app_country] => US
[patent_app_date] => 1995-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11939
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/559/05559104.pdf
[firstpage_image] =>[orig_patent_app_number] => 439437
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/439437 | Procedure for the purification of hyaluronic acid and fraction of pure hyaluronic acid for ophthalmic use | May 10, 1995 | Issued |
Array
(
[id] => 4306994
[patent_doc_number] => 06326476
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-04
[patent_title] => 'Heparin derivatives and process for the preparation thereof'
[patent_app_type] => 1
[patent_app_number] => 8/438933
[patent_app_country] => US
[patent_app_date] => 1995-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 7
[patent_no_of_words] => 6364
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/326/06326476.pdf
[firstpage_image] =>[orig_patent_app_number] => 438933
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/438933 | Heparin derivatives and process for the preparation thereof | May 9, 1995 | Issued |
| 90/003836 | METHOD FOR PREPARING HIGH-PURITY CRYSTALLINE LACTULOSE | May 9, 1995 | Issued |
Array
(
[id] => 3693977
[patent_doc_number] => 05679658
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-10-21
[patent_title] => 'N,O-carbonxymethylchitosan for prevention of surgical adhesions'
[patent_app_type] => 1
[patent_app_number] => 8/436770
[patent_app_country] => US
[patent_app_date] => 1995-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3226
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/679/05679658.pdf
[firstpage_image] =>[orig_patent_app_number] => 436770
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/436770 | N,O-carbonxymethylchitosan for prevention of surgical adhesions | May 7, 1995 | Issued |
Array
(
[id] => 3531795
[patent_doc_number] => 05583208
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-12-10
[patent_title] => 'Ganglioside GM3 derivatives containing fluorine in ceramide portion'
[patent_app_type] => 1
[patent_app_number] => 8/432185
[patent_app_country] => US
[patent_app_date] => 1995-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21680
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/583/05583208.pdf
[firstpage_image] =>[orig_patent_app_number] => 432185
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/432185 | Ganglioside GM3 derivatives containing fluorine in ceramide portion | May 7, 1995 | Issued |
| 08/435775 | HEPARIN FRACTION WITH ANTI-HIV ACTIVITY | May 4, 1995 | Abandoned |
| 08/435664 | MYELOGLYCAN | May 4, 1995 | Abandoned |
| 08/433298 | OLIGOSACCHARIDE STRUCTURE OF A LIGAND FOR E AND P SELECTIN | May 2, 1995 | Abandoned |
Array
(
[id] => 3698097
[patent_doc_number] => 05677285
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-10-14
[patent_title] => 'Derivatives of neuraminic acid'
[patent_app_type] => 1
[patent_app_number] => 8/379602
[patent_app_country] => US
[patent_app_date] => 1995-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19947
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/677/05677285.pdf
[firstpage_image] =>[orig_patent_app_number] => 379602
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/379602 | Derivatives of neuraminic acid | Apr 25, 1995 | Issued |
Array
(
[id] => 3770182
[patent_doc_number] => 05849716
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-12-15
[patent_title] => 'Sphingoglycolipids, their preparation, and therapeutic methods of use'
[patent_app_type] => 1
[patent_app_number] => 8/416917
[patent_app_country] => US
[patent_app_date] => 1995-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 19380
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/849/05849716.pdf
[firstpage_image] =>[orig_patent_app_number] => 416917
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/416917 | Sphingoglycolipids, their preparation, and therapeutic methods of use | Apr 20, 1995 | Issued |